GSK424887

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Depressive Disorder and Anxiety Disorders

Phase 1

First Study in Humans With GSK424887

CompletedNCT01059591

GlaxoSmithKlineDepressive Disorder and Anxiety Disorders

Start: 2006-05-25End: 2007-01-25Updated: 2017-08-11

Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic

CompletedNCT01424384

GlaxoSmithKlineDepressive Disorder and Anxiety Disorders

Start: 2008-09-19End: 2009-04-30Updated: 2017-07-07